What Is the Starting Dose of Wegovy? A Prescriber's Walkthrough

What Is the Starting Dose of Wegovy? A Prescriber's Walkthrough

By Dr. Onikepe Adegbola, MD PhD

The starting dose of Wegovy is 0.25 mg once weekly, injected subcutaneously. This is not a therapeutic dose — it's an initiation dose designed to let your gastrointestinal system adjust to semaglutide before moving to higher, more effective doses. Every patient starts here, regardless of body weight, prior medication history, or how urgently they want results.

I walk patients through this at their first visit because misunderstanding the dose schedule is one of the most common sources of frustration. You won't lose much weight at 0.25 mg. That's expected. Here's the full escalation schedule and the reasoning behind each step.

The Wegovy Dose Escalation Schedule

Wegovy uses a five-step dose escalation over 16 weeks before reaching the maintenance dose. Each step lasts 4 weeks:

• Weeks 1-4: 0.25 mg weekly (starting dose — GI initiation only)
• Weeks 5-8: 0.5 mg weekly (still sub-therapeutic for most patients)
• Weeks 9-12: 1 mg weekly (first dose where meaningful appetite suppression begins)
• Weeks 13-16: 1.7 mg weekly (strong appetite and weight loss effects for most)
• Week 17 onward: 2.4 mg weekly (full maintenance dose)

This schedule is identical for all patients. There's no weight-based dosing, no gender adjustment, no shortcut. The FDA labeling is explicit on this point.

Why Start So Low?

Semaglutide slows gastric emptying, modulates central appetite circuits, and alters GI motility. Introducing these effects abruptly — say, starting at 2.4 mg — would produce severe nausea, vomiting, and diarrhea in most patients. The escalation exists to give your body time to adapt.

In clinical trials, even with the gradual titration, about 44% of patients reported nausea at some point. Without it, that number would be higher and the severity worse. Patients who've tried to skip ahead (usually with compounded semaglutide) learn this lesson fast.

The 0.25 mg starting dose of Wegovy accomplishes one thing: it tells your GI tract that a new signaling molecule is in play. The metabolic heavy lifting comes later.

What to Expect at the Starting Dose

At 0.25 mg, most patients notice very little. Some report mild appetite reduction. A few experience light nausea. Many feel nothing at all and wonder if the medication is working. It is — it's doing exactly what it's supposed to do at this stage, which is quietly acclimate your system.

Patients who are anxious about the starting dose of Wegovy being "too low" should know: meaningful weight loss data from the STEP trials was measured from the start of treatment, including these early initiation weeks. The 0.25 mg phase isn't wasted time. It's part of the protocol that produced 15-17% average weight loss over 68 weeks.

What I tell patients to focus on during the first month: hydration, protein intake, and building the habits that will matter once the appetite suppression kicks in at higher doses. If you wait until you're at 2.4 mg to figure out how to eat 80g of protein on reduced appetite, you're behind.

When Does the Starting Dose of Wegovy Actually Start Working?

Define "working." If you mean measurable weight loss on a scale — most patients start noticing this around weeks 9-12, at the 1 mg dose. If you mean detectable changes in appetite — often by weeks 5-8 at the 0.5 mg dose, sometimes earlier.

But the physiology starts changing from day one. Fasting glucose improves. Postprandial glucose excursions get smaller. Insulin sensitivity begins shifting. You just can't feel those changes the way you can feel not wanting lunch.

Can Your Prescriber Slow Down the Escalation?

Yes. The 4-week-per-step schedule is the minimum duration at each dose. If you're experiencing significant GI side effects at 0.5 mg, your prescriber might keep you there for 6 or 8 weeks before advancing. This doesn't reduce the medication's long-term effectiveness — it just means a longer ramp to the full dose.

I do this regularly in my practice. Patients with a history of gastroparesis, IBS, or severe GERD sometimes benefit from a slower escalation. The endpoint is the same; the path there is just gentler.

What prescribers should not do is skip doses or jump from 0.25 mg to 1 mg because a patient "isn't seeing results." Each dose step serves a purpose.

Managing Side Effects at the Starting Dose

Even at 0.25 mg, some patients experience GI symptoms. The most common:

• Mild nausea — typically after injection, lasting a few hours to a day
• Constipation — due to slowed gastric motility
• Decreased appetite — usually subtle at this dose
• Injection site reactions — redness or mild soreness, self-limited

These are rarely severe at the starting dose. If they are, it's a signal to your prescriber that you may need a particularly slow titration.

Practical strategies that help: eat smaller meals. Stay hydrated. Avoid high-fat meals, which sit in the stomach longer and compound the slowed emptying. Consider digestive support — Casa de Sante GLP-1 supplements were designed for exactly this population, with low FODMAP formulations that support GI comfort during the dose escalation process.

The Starting Dose of Wegovy Compared to Other GLP-1 Medications

Patients transitioning between GLP-1 medications often ask how the Wegovy starting dose compares to others in the class. Here's how they compare:

• Ozempic: Also starts at 0.25 mg weekly. Same molecule (semaglutide), identical starting phase. The divergence happens at higher doses — Ozempic maxes out at 2 mg for diabetes, while Wegovy goes to 2.4 mg for weight management.
• Mounjaro/Zepbound (tirzepatide): Starts at 2.5 mg weekly. Different molecule, different receptor targets, not directly comparable in milligrams. The 2.5 mg tirzepatide starting dose is also a GI initiation dose, not a therapeutic dose.
• Saxenda (liraglutide): Starts at 0.6 mg daily. Escalates in 0.6 mg increments weekly to a maximum of 3 mg daily. Daily dosing versus Wegovy's weekly dosing is the primary practical difference.

If you're switching from Ozempic to Wegovy — which happens commonly when the clinical goal shifts from diabetes management to weight loss — your prescriber may not restart at 0.25 mg if you're already tolerating a higher semaglutide dose. This is an off-label clinical decision based on your current dose and tolerance, not a labeled recommendation. The standard labeled approach still starts at 0.25 mg.

Nutritional Preparation During the Starting Phase

The first month at the starting dose of Wegovy is the ideal window to establish nutritional habits that become critical later. Once appetite suppression intensifies at higher doses, getting adequate nutrition requires intentional effort.

Protein is the highest priority. Muscle mass preservation during GLP-1-mediated weight loss depends heavily on protein intake and resistance training. I recommend patients aim for 1.2-1.6g of protein per kg of ideal body weight per day — a target that's achievable at the starting dose when appetite is still relatively normal, but becomes challenging at 1.7 mg or 2.4 mg without planning.

Casa de Sante GLP-1 supplements address this directly — the protein powders and daily vitamin complex are formulated for the low-appetite, GI-sensitive reality of GLP-1 therapy. Starting them during the initiation phase means your nutritional foundation is solid before the doses climb.

Frequently Asked Questions

Can I start Wegovy at a higher dose than 0.25 mg?

No. The FDA-approved protocol requires starting at 0.25 mg regardless of patient characteristics. Starting at a higher dose significantly increases the risk of severe GI side effects. Even patients switching from Ozempic (which contains the same molecule) typically restart the Wegovy titration schedule, though your prescriber may adjust this based on your current semaglutide dose.

What happens if I miss a dose during the starting phase?

If your missed dose is within 5 days of the scheduled injection, take it as soon as you remember. If more than 5 days have passed, skip the missed dose and take the next one on your regular day. You do not need to restart the titration from the beginning after a single missed dose.

Is the starting dose of Wegovy the same as the starting dose of Ozempic?

Yes. Both Wegovy and Ozempic start at 0.25 mg weekly. The key difference is in the maintenance dose: Ozempic's maximum is 2 mg (for diabetes), while Wegovy goes up to 2.4 mg (for weight management). The titration schedules also differ slightly at higher doses.

Why am I not losing weight on Wegovy 0.25 mg?

Because 0.25 mg is not a weight loss dose. It's a GI tolerability initiation dose. This is normal and expected. Weight loss typically becomes apparent at the 1 mg level and accelerates at 1.7 mg and 2.4 mg. The first month is about your body adjusting, not about the scale.

How long does it take to reach the full dose of Wegovy?

Following the standard escalation, you reach the full 2.4 mg maintenance dose at week 17. If your prescriber slows the titration due to side effects, it may take longer. The median time to reach maintenance in clinical practice is about 4-5 months.